New Analyses of Sotagliflozin Showing Time to Clinical Benefit Presented at The American College of Cardiology’s 72nd Annual Scientific Session Together With World Heart Federation’s World Congress of Cardiology

March 5, 2023

https://www.globenewswire.com/news-release/2023/03/04/2620614/0/en/New-Analyses-of-Sotagliflozin-Showing-Time-to-Clinical-Benefit-Presented-at-The-American-College-of-Cardiology-s-72nd-Annual-Scientific-Session-Together-With-World-Heart-Federation.html

Statistically significant reduction in the risk for the primary outcome on Day 27

Findings generally consistent across the left ventricular ejection fraction (LVEF) range

Read more at globenewswire.com

Related news for (LXRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.